参考文献（第3/3页）

［60］Druker B J，et al．Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia［J］．N Engl J Med，2006，355（23）：2408-2417.

［61］Lundkvist J，et al．Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma［J］．Cancer，2005，103（4）：793-801.

［62］Ludwig J A，Weinstein J N．Biomarkers in cancer staging，prognosis and treatment selection［J］．Nat Rev Cancer，2005，5（11）：845-856.

［63］van der Zee，J．Heating the patient：a promising approach？［J］．Ann Oncol，2002，13（8）：1173-1184.

［64］Srivastava S R．Gopal-Srivastava，Biomarkers in cancer screening：a public health perspective［J］．J Nutr，2002，132（8 Suppl）：2471S-2475S.

［65］Miralbell R，et al．Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors［J］．Int J Radiat Oncol Biol Phys，2002，54（3）：824-829.

［66］Nishimura H，et al．Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor［J］．Immunity，1999，11（2）：141-151.

［67］Patterson R E，et al．Vitamin supplements and cancer risk：the epidemiologic evidence［J］．Cancer Causes Control，1997，8（5）：786-802.

［68］Jha P，et al．The antioxidant vitamins and cardiovascular disease．A critical review of epidemiologic and clinical trial data［J］．Ann Intern Med，1995，123（11）：860-872.

［69］Ferrara J L，Abhyankar S，Gilliland D G.Cytokine storm of graft-versus-host disease：a critical effector role for interleukin-1［J］．Transplant Proc，1993，25（1 Pt 2）：1216-1217.

［70］Newcomb P A，Carbone P P．The health consequences of smoking．Cance［J］r．Med Clin North Am，1992，76（2）：305-331.

［71］Martuza R L，et al．Experimental therapy of human glioma by means of a genetically engineered virus mutant［J］．Science，1991，252（5007）：854-856.

［72］Rosenberg S A，et al．Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer［J］．N Engl J Med，1985，313（23）：1485-1492.

［73］Morahan P S，et al．Paradoxical effects of immunopotentiators on tumors and tumor viruses［J］．J Infect Dis，1976，133 Suppl：A249-255.

［74］Yohn D S，et al.Oncolytic potentials of nonhuman viruses for human cancer．Ⅱ．Effects of five viruses on heterotransplantable human tumors［J］．J Natl Cancer Inst，1968，41（2）：523-529.

［75］Moore A E．Effects of viruses on tumors［J］．Annu Rev Microbiol，1954，8：393-410.

［76］Southam C M，Moore A E．Clinical studies of viruses as antineoplastic agents with particular reference to Egypt 101 virus［J］．Cancer，1952，5（5）：1025-1034.

［77］CBSnews .Killing Cancer［OL］．http://www.cbsnews.com/news/polio-cancer-treatment-duke-university-60-minutes-scott-pelley/2015，3.29.

［78］https://clinicaltrials.gov/ct2/show/NCT0149189

［79］Li Z，et.al，Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells［J］．Cancer Cell．2009，2；15（6）：501-513.

［80］Gromeier M．et.al，Oncolytic polio virotherapy of cancer.Cancer［J］．2014，120（21）：3277-3286.